查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1671907

迷走神經刺激設備市場：按產品類型、按應用、按材料類型、按最終用戶、按地區

Vagus Nerve Stimulators Market, By Product Type, By Application, By Material Type , By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 162 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年全球迷迷走神經刺激設備市場規模估計為 6.674 億美元，預計到 2032 年將達到 12.931 億美元，2025 年至 2032 年的複合年成長率為 9.9%。

報告範圍 報告詳細資訊
基準年 2024 2025 年市場規模 6.674億美元
效能資料 2020-2024 預測期 2025-2032
預測期：2025-2032年複合年成長率： 9.90％ 2032 年價值預測 12.931億美元
數字。 2025 年迷走神經刺激設備各地區市場佔有率（%）
迷走神經刺激器市場 - IMG1

迷走神經是最長的腦神經，與心臟等身體的多個器官相互作用。迷走神經刺激 (VNS) 涉及使用稱為迷走神經刺激設備的植入式醫療設備向迷走神經傳送電脈衝。這種治療方法是基於刺激迷走神經可以控制異常大腦活動並抑制癲癇發作的原理。迷走神經刺激設備可作為輔助性治療，減少藥物無法充分控制的癲癇患者的發作頻率和嚴重程度。人們也正在探索VNS在治療其他神經和精神疾病（如憂鬱症、阿茲海默症和偏頭痛）方面的治療潛力。

市場動態：

全球迷迷走神經刺激設備市場的發展受到癲癇和其他神經系統疾病盛行率上升、人們對迷走神經刺激器療法的認知和接受度不斷提高以及有利的報銷政策的推動。然而，迷走神經刺激設備和手術的高成本以及與迷走神經刺激相關的副作用和併發症是市場成長的主要限制因素。功能增強的創新刺激器的開發和 VNS 治療應用的擴展為高效渲染提供了機會。相關人員正在投資研究試驗，以評估 VNS 在抗治療性憂鬱症、類風濕性關節炎和心臟衰竭等疾病方面的有效性。

本研究的主要特點

  • 本研究報告對全迷走神經刺激設備市場進行了詳細分析，並提供了預測期（2025-2032）的市場規模和年複合成長率（CAGR%），以 2024 年為基準年。
  • 它揭示了不同領域的潛在收益成長機會，並解釋了該市場的引人注目的投資提案矩陣。
  • 它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
  • 報告根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數，概述了全迷走神經刺激設備市場的主要企業。
  • 本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 全球迷迷走神經刺激設備市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
  • 相關人員可以透過分析全迷走神經刺激設備市場所使用的各種策略矩陣來簡化決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章市場動態、法規與趨勢分析

  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
  • 影響分析
  • 管道分析
  • PEST分析
  • 監管情景
  • 市場趨勢
  • 主要亮點
  • 退款情形
  • 合併和收購

4. 全迷走神經刺激設備市場 - 冠狀病毒 (COVID-19) 大流行的影響

  • 經濟影響
  • 對臨床試驗和藥物開發的影響
  • 政府舉措

5. 2020 年至 2032 年全迷走神經刺激設備市場（依產品類型）

  • 嵌入式裝置
  • 外部設備

6. 2020 年至 2032 年全迷走神經刺激設備市場（依應用）

  • 癲癇
  • 憂鬱症和焦慮
  • 偏頭痛
  • 其他

7. 2020 年至 2032 年全迷走神經刺激設備市場（依材料類型）

  • 陶瓷製品
  • 金屬
  • 聚合物

8. 全迷走神經刺激設備市場，依最終用戶分類，2020 年至 2032 年

  • 醫院
  • 專科門診
  • 門診手術中心
  • 其他

9. 2020 年至 2032 年全迷走神經刺激設備市場（按地區）

  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第10章 競爭格局

  • 熱圖分析
  • 市場佔有率分析
    • LivaNova PLC
    • electroCore, Inc.
    • SetPoint Medical Corporation
    • Beijing PINS Medical Co., Ltd.
    • Parasym Ltd.
    • Nervana, LLC
    • tVNS Technologies GmbH
    • BioControl Medical
    • NeurAxis, Inc.
    • Soterix Medical Inc.
    • MicroTransponder Inc.
    • Boston Scientific Corporation
    • Cyberonics, Inc.
    • EnteroMedics Inc.
    • ReShape Lifesciences Inc.
    • Cerbomed GmbH

第 11 章 分析師觀點

  • 命運之輪
  • 分析師觀點
  • 一致的機會地圖

第 12 章參考文獻與調查方法

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI2514

Global Vagus Nerve Stimulators Market is estimated to be valued at USD 667.4 Mn in 2025 and is expected to reach USD 1,293.1 Mn by 2032, growing at a compound annual growth rate (CAGR) of 9.9% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 667.4 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 9.90% 2032 Value Projection: USD 1,293.1 Mn
Figure. Vagus Nerve Stimulators Market Share (%), By Region 2025
Vagus Nerve Stimulators Market - IMG1

The vagus nerve is the longest cranial nerve that interacts with several organs of the body including the heart. Vagus nerve stimulation or VNS involves delivering electrical pulses to the vagus nerve using an implantable medical device called a vagus nerve stimulator. This therapy relies on the principle that stimulating the vagus nerve can help regulate abnormal brain activity and seizure control. Vagus nerve stimulators are used as an adjunctive therapy for reducing the frequency and severity of seizures in patients with epilepsy whose conditions are not fully controlled by medications. The therapeutic potential of VNS is being explored for treating other neurological and psychiatric disorders such as depression, Alzheimer's disease, and migraine too.

Market Dynamics:

The global vagus nerve stimulators market is driven by the rising prevalence of epilepsy and other neurological disorders, growing awareness and acceptance of VNS therapy, and favorable reimbursement policies. However, high costs associated with VNS devices and surgeries coupled with adverse effects and complications associated with stimulation of the vagus nerve act as key restraints for the market growth. Development of innovative stimulation devices with improved features and expanding therapeutic applications of VNS present high-impact rendering opportunities. Stakeholders are investing in research trials to evaluate the efficacy of VNS in conditions such as treatment-resistant depression, rheumatoid arthritis, and heart failure.

Key Features of the Study:

  • This report provides an in-depth analysis of the global vagus nerve stimulators market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global vagus nerve stimulators market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include LivaNova PLC, electroCore Inc., SetPoint Medical Corporation, Beijing PINS Medical Co. Ltd., Parasym Ltd., Nervana LLC, tVNS Technologies GmbH, BioControl Medical, NeurAxis Inc., Soterix Medical Inc., MicroTransponder Inc., Boston Scientific Corporation, Cyberonics Inc., EnteroMedics Inc., ReShape Lifesciences Inc., and Cerbomed GmbH.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global vagus nerve stimulators market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vagus nerve stimulators market.

Market Segmentation

  • Product Type:
    • Implantable Devices
    • External Devices
  • Application:
    • Epilepsy
    • Depression & Anxiety
    • Migraine
    • Others
  • Material Type:
    • Ceramics
    • Metallics
    • Polymerics
  • End User:
    • Hospitals
    • Specialty Clinics
    • Ambulatory Surgical Centers
    • Others
  • Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • LivaNova PLC
    • electroCore Inc.
    • SetPoint Medical Corporation
    • Beijing PINS Medical Co. Ltd.
    • Parasym Ltd.
    • Nervana LLC
    • tVNS Technologies GmbH
    • BioControl Medical
    • NeurAxis Inc.
    • Soterix Medical Inc.
    • MicroTransponder Inc.
    • Boston Scientific Corporation
    • Cyberonics Inc.
    • EnteroMedics Inc.
    • ReShape Lifesciences Inc.
    • Cerbomed GmbH

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Application
    • Market Snippet, By Material Type
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Pipeline Analysis
  • PEST Analysis
  • Regulatory Scenario
  • Market Trends
  • Key Highlights
  • Reimbursement Scenario
  • Mergers & Acquisitions

4. Global Vagus Nerve Stimulators Market - Impact of Coronavirus (COVID-19) Pandemic

  • Economic Impact
  • Impact on Clinical Trials and Drug Development
  • Government Initiatives

5. Global Vagus Nerve Stimulators Market, By Product Type, 2020 - 2032, (USD MN)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Implantable Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD MN)
  • External Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD MN)

6. Global Vagus Nerve Stimulators Market, By Application, 2020 - 2032, (USD MN)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Epilepsy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD MN)
  • Depression & Anxiety
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD MN)
  • Migraine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD MN)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD MN)

7. Global Vagus Nerve Stimulators Market, By Material Type, 2020 - 2032, (USD MN)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Ceramics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD MN)
  • Metallics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD MN)
  • Polymerics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD MN)

8. Global Vagus Nerve Stimulators Market, By End User, 2020 - 2032, (USD MN)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD MN)
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD MN)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD MN)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD MN)

9. Global Vagus Nerve Stimulators Market, By Region, 2020 - 2032, (USD MN)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2032
  • North America
    • Market Size and Forecast, By Product Type, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By Material Type, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD MN)
      • U.S.
      • Canada
  • Latin America
    • Market Size and Forecast, By Product Type, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By Material Type, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD MN)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Product Type, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By Material Type, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD MN)
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By Material Type, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD MN)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Product Type, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By Material Type, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD MN)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Product Type, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By Material Type, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD MN)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, (USD MN)
      • South Africa
      • Central Africa
      • North Africa

10. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • LivaNova PLC
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • electroCore, Inc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • SetPoint Medical Corporation
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Beijing PINS Medical Co., Ltd.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Parasym Ltd.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Nervana, LLC
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • tVNS Technologies GmbH
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • BioControl Medical
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • NeurAxis, Inc.
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Soterix Medical Inc.
    • MicroTransponder Inc.
    • Boston Scientific Corporation
    • Cyberonics, Inc.
    • EnteroMedics Inc.
    • ReShape Lifesciences Inc.
    • Cerbomed GmbH

11. Analyst View

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact